Risk of dementia in parents of probands with and without the apolipoprotein E4 allele. The EVA study

被引:2
作者
Danet, S
Brousseau, T
Richard, F
Amouyel, P
Berr, C [1 ]
机构
[1] Hop La Pitie Salpetriere, INSERM, U360, F-75651 Paris 13, France
[2] Inst Pasteur, INSERM, U508, Serv Epidemiol & Sante Publ, F-59019 Lille, France
关键词
D O I
10.1136/jech.53.7.393
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Study objective-Age, family history of dementia and the epsilon 4 allele of the apolipoprotein E gene have been associated with Alzheimer's disease (AD). Considering the strength of APOE-epsilon 4 as a genetic risk factor for AD, this factor might explain a large part of the association between AD and a family history of dementia. Therefore, in the general population, a higher frequency of dementia should be observed among parents of probands with at least one epsilon 4 allele than in parents of probands without this allele. Design, setting, and participants-The study investigated a sample of 1153 volunteers between 59 and 71 years old, genotyped for the APOE gene, all participating in the EVA study. Dementia in their parents was determined using a self reported questionnaire. Main results-The frequency of dementia in 2164 parents was examined and it was found that 245 were demented. The percentage of demented parents was 13.0% in the subgroup of parents of subjects having one or two epsilon 4 alleles and 10.8% in the other subgroup. The relative risk of dementia among parents according to the APOE-epsilon 4 status of probands, was calculated using a Cox model adjusted for the educational level of parents and their history of stroke: RR = 1.21 (95% CI 0.90, 1.63). Conclusion-This lack of association supports the observation that in the general population, APOE-epsilon 4 cannot explain a large part of family history of dementia.
引用
收藏
页码:393 / 398
页数:6
相关论文
共 36 条
[11]  
GREEN MS, 1990, AM J EPIDEMIOL, V43, P941
[12]   SENILE DEMENTIA OF THE LEWY BODY TYPE HAS AN APOLIPOPROTEIN-E EPSILON-4 ALLELE FREQUENCY INTERMEDIATE BETWEEN CONTROLS AND ALZHEIMERS-DISEASE [J].
HARDY, J ;
CROOK, R ;
PRIHAR, G ;
ROBERTS, G ;
RAGHAVAN, R ;
PERRY, R .
NEUROSCIENCE LETTERS, 1994, 182 (01) :1-2
[13]   Validity of the family history method in relatives of gerontopsychiatric patients [J].
Heun, R ;
Hardt, J ;
Burkart, M ;
Maier, W .
PSYCHIATRY RESEARCH, 1996, 62 (03) :227-238
[14]  
HIXSON JE, 1990, J LIPID RES, V31, P545
[15]   Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study [J].
Hofman, A ;
Ott, A ;
Breteler, MMB ;
Bots, ML ;
Slooter, AJC ;
vanHarskamp, F ;
vanDuijn, CN ;
Van Broeckhoven, C ;
Grobbee, DE .
LANCET, 1997, 349 (9046) :151-154
[16]   THE PREVALENCE OF DEMENTIA IN EUROPE - A COLLABORATIVE STUDY OF 1980-1990 FINDINGS [J].
HOFMAN, A ;
ROCCA, WA ;
BRAYNE, C ;
BRETELER, MMB ;
CLARKE, M ;
COOPER, B ;
COPELAND, JRM ;
DARTIGUES, JF ;
DROUX, AD ;
HAGNELL, O ;
HEEREN, TJ ;
ENGEDAL, K ;
JONKER, C ;
LINDESAY, J ;
LOBO, A ;
MANN, AH ;
MOLSA, PK ;
MORGAN, K ;
OCONNOR, DW ;
SULKAVA, R ;
KAY, DWK ;
AMADUCCI, L .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1991, 20 (03) :736-748
[17]   APOLIPOPROTEIN-E GENOTYPES IN PARKINSON DISEASE WITH AND WITHOUT DEMENTIA [J].
KOLLER, WC ;
GLATT, SL ;
HUBBLE, JP ;
PAOLO, A ;
TROSTER, AI ;
HANDLER, MS ;
HORVAT, RT ;
MARTIN, C ;
SCHMIDT, K ;
KARST, A ;
WIJSMAN, EM ;
YU, CE ;
SCHELLENBERG, GD .
ANNALS OF NEUROLOGY, 1995, 37 (02) :242-245
[18]   ASSOCIATION OF APOLIPOPROTEIN-E PHENOTYPES WITH LATE-ONSET ALZHEIMERS-DISEASE - POPULATION-BASED STUDY [J].
KUUSISTO, J ;
KOIVISTO, K ;
KERVINEN, K ;
MYKKANEN, L ;
HELKALA, EL ;
VANHANEN, M ;
HANNINEN, T ;
PYORALA, K ;
KESANIEMI, YA ;
RIEKKINEN, P ;
LAAKSO, M .
BRITISH MEDICAL JOURNAL, 1994, 309 (6955) :636-638
[19]   INCIDENCE OF DEMENTIA AND ALZHEIMERS-DISEASE IN ELDERLY COMMUNITY RESIDENTS OF SOUTH-WESTERN FRANCE [J].
LETENNEUR, L ;
COMMENGES, D ;
DARTIGUES, JF ;
BARBERGERGATEAU, P .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1994, 23 (06) :1256-1261
[20]  
Li G, 1996, GENET EPIDEMIOL, V13, P285, DOI 10.1002/(SICI)1098-2272(1996)13:3<285::AID-GEPI5>3.0.CO